Abstract
In summary, our study reveals a relatively high expression of complement regulatory proteins on the surface of plasma cells, which appears to be a constitutive feature of these cells, rather than a specific change induced by a malignant state. Further efforts will aim at establishing a correlation between CD55 and CD59 expression levels and in vitro and in vivo resistance to rituximab.
Original language | English (US) |
---|---|
Pages (from-to) | 919-921 |
Number of pages | 3 |
Journal | Leukemia and Lymphoma |
Volume | 47 |
Issue number | 5 |
DOIs | |
State | Published - May 2006 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research